140 related articles for article (PubMed ID: 3958353)
21. Comparison of programmed electrical stimulation and ambulatory electrocardiographic (Holter) monitoring in the management of ventricular tachycardia and ventricular fibrillation.
Platia EV; Reid PR
J Am Coll Cardiol; 1984 Sep; 4(3):493-500. PubMed ID: 6470328
[TBL] [Abstract][Full Text] [Related]
22. Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease.
Zhu J; Haines DE; Lerman BB; DiMarco JP
Circulation; 1987 Oct; 76(4):802-9. PubMed ID: 3652422
[TBL] [Abstract][Full Text] [Related]
23. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
[TBL] [Abstract][Full Text] [Related]
24. Chronic effects of amiodarone in patients with refractory ventricular tachycardia.
Saksena S; Rothbart ST; Cappello G
Int J Cardiol; 1983 Jun; 3(3):339-52. PubMed ID: 6347914
[TBL] [Abstract][Full Text] [Related]
25. Invasive and noninvasive methods to predict the long-term efficacy of amiodarone: a compilation of clinical observations using meta-analysis.
Roberts SA; Viana MA; Nazari J; Bauman JL
Pacing Clin Electrophysiol; 1994 Oct; 17(10):1590-602. PubMed ID: 7800560
[TBL] [Abstract][Full Text] [Related]
26. Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation: risk stratification based on clinical variables.
DiCarlo LA; Morady F; Sauve MJ; Malone P; Davis JC; Evans-Bell T; Winston SA; Scheinman MM
Am J Cardiol; 1985 Feb; 55(4):372-4. PubMed ID: 3969871
[TBL] [Abstract][Full Text] [Related]
27. Amiodarone in refractory life-threatening ventricular arrhythmias.
Nademanee K; Singh BN; Hendrickson J; Intarachot V; Lopez B; Feld G; Cannom DS; Weiss JL
Ann Intern Med; 1983 May; 98(5 Pt 1):577-84. PubMed ID: 6846970
[TBL] [Abstract][Full Text] [Related]
28. Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias.
Podrid PJ; Lown B
Am Heart J; 1981 Apr; 101(4):374-9. PubMed ID: 7211665
[TBL] [Abstract][Full Text] [Related]
29. The role of Holter monitoring in patients with recurrent sustained ventricular tachycardia: an electrophysiologic correlation.
Ezri MD; Huang SK; Denes P
Am Heart J; 1984 Nov; 108(5):1229-36. PubMed ID: 6496281
[TBL] [Abstract][Full Text] [Related]
30. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
[TBL] [Abstract][Full Text] [Related]
31. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.
McKenna WJ; Oakley CM; Krikler DM; Goodwin JF
Br Heart J; 1985 Apr; 53(4):412-6. PubMed ID: 4039188
[TBL] [Abstract][Full Text] [Related]
32. A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia.
Mitchell LB; Duff HJ; Manyari DE; Wyse DG
N Engl J Med; 1987 Dec; 317(27):1681-7. PubMed ID: 3320747
[TBL] [Abstract][Full Text] [Related]
33. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
34. Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias.
Hamer AW; Finerman WB; Peter T; Mandel WJ
Am Heart J; 1981 Dec; 102(6 Pt 1):992-1000. PubMed ID: 7315716
[TBL] [Abstract][Full Text] [Related]
35. Ambulatory electrocardiographic correlates of ventricular inducibility during programmed electrical stimulation.
Gradman AH; Batsford WP; Rieur EC; Leon L; Van Zetta AM
J Am Coll Cardiol; 1985 May; 5(5):1087-93. PubMed ID: 3989118
[TBL] [Abstract][Full Text] [Related]
36. Amiodarone: correlation of serum concentration with suppression of complex ventricular ectopic activity.
Mostow ND; Rakita L; Vrobel TR; Noon DL; Blumer J
Am J Cardiol; 1984 Sep; 54(6):569-74. PubMed ID: 6475775
[TBL] [Abstract][Full Text] [Related]
37. Intravenous and oral loading versus oral loading alone with amiodarone for chronic refractory ventricular arrhythmias.
Kerin NZ; Blevins RD; Frumin H; Faitel K; Rubenfire M
Am J Cardiol; 1985 Jan; 55(1):89-91. PubMed ID: 3966403
[TBL] [Abstract][Full Text] [Related]
38. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
Tsuchiya M; Kasanuki H; Ohnishi S; Hosoda S
J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400
[TBL] [Abstract][Full Text] [Related]
39. [Comparison between amiodarone and disopyramide in the treatment of ventricular extrasystoles].
Gaudeau B; Badouraly A; Herpin D; Tournadre P; Boutaud P; Amiel A; Guillem JP; Demange J
Ann Cardiol Angeiol (Paris); 1986 Jan; 35(1):43-8. PubMed ID: 2421631
[TBL] [Abstract][Full Text] [Related]
40. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
